We report two cases of pregnancy in patients taking TNFalpha antagonists for chronic inflammatory joint disease.
METHODS : A standardized stress task was administered to 3 groups of subjects : RA patients taking TNFalpha antagonists , RA patients not taking such medications , and healthy controls.
METHODS : Two complementary approaches were taken : in the first ` in vitro ' approach monocyte-derived DC from healthy donors were matured with lipopolysaccharide and treated with TNFalpha antagonists in vitro for 48 h. In the second ` ex vivo ' approach monocyte-derived DC were generated from RA patients before and 8-12 weeks into anti-TNFalpha treatment.
In this study , we sought to investigate the effect of ischemia on DC activity in vitro.